Calamos Advisors LLC Invests $740,000 in BlackRock Health Sciences Term Trust $BMEZ

Calamos Advisors LLC acquired a new stake in BlackRock Health Sciences Term Trust (NYSE:BMEZ) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 51,559 shares of the company’s stock, valued at approximately $740,000.

Several other institutional investors and hedge funds have also modified their holdings of BMEZ. Kestra Advisory Services LLC acquired a new stake in BlackRock Health Sciences Term Trust during the fourth quarter worth approximately $26,000. Geneos Wealth Management Inc. acquired a new position in BlackRock Health Sciences Term Trust in the 1st quarter valued at $40,000. Allworth Financial LP raised its holdings in BlackRock Health Sciences Term Trust by 24,584.6% in the 3rd quarter. Allworth Financial LP now owns 3,209 shares of the company’s stock valued at $46,000 after acquiring an additional 3,196 shares during the last quarter. CWM LLC raised its holdings in BlackRock Health Sciences Term Trust by 25.6% in the 4th quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after acquiring an additional 680 shares during the last quarter. Finally, Fifth Third Bancorp purchased a new position in shares of BlackRock Health Sciences Term Trust during the 1st quarter worth $142,000.

BlackRock Health Sciences Term Trust Stock Performance

BMEZ stock opened at $15.23 on Friday. BlackRock Health Sciences Term Trust has a 52-week low of $13.67 and a 52-week high of $15.80. The stock’s fifty day simple moving average is $14.69 and its 200-day simple moving average is $14.72.

BlackRock Health Sciences Term Trust Announces Dividend

The firm also recently announced a monthly dividend, which will be paid on Wednesday, September 30th. Investors of record on Tuesday, September 15th will be paid a $0.11 dividend. This represents a c) annualized dividend and a yield of 8.7%. The ex-dividend date is Tuesday, September 15th.

BlackRock Health Sciences Term Trust Company Profile

BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.

The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.